Executive Summary
An unprecedented surge of 52 8-K filings on February 25, 2026, all disclosing Item 5.02 board/officer changes (departures, appointments, elections, compensatory arrangements), with zero specific details on positions (e.g., CEO/CFO), individuals, reasons, or timing across every filing, creating uniform disclosure opacity and elevated governance uncertainty. No period-over-period comparisons, quantitative financial metrics, insider trading activity, capital allocation details, M&A transactions, forward-looking guidance, or operational metrics were disclosed in any filing, preventing trend analysis but highlighting a portfolio-level pattern of non-transparent leadership shifts. Healthcare/biotech dominates with 9 companies (17%), followed by consumer/retail (10%) and hospitality (6%), suggesting sector-specific board refreshes potentially tied to performance or regulatory pressures. Sentiment is unanimously neutral, but average materiality 4.6/10 and 60%+ medium risk flags signal potential instability, especially Permex Petroleum's concurrent Item 2.04 financial obligation trigger. 18 filings include Item 2.02 results or Item 7.01 Reg FD, implying changes amid earnings contexts without disclosed numbers. Market implication: near-term volatility spike in affected small/mid-caps; actionable to avoid or short opacity-heavy names pending follow-up disclosures.
Tracking the trend? Catch up on the prior US Corporate Board Director Changes SEC Filings digest from February 23, 2026.
Investment Signals(12)
- Permex Petroleum Corp↓(BEARISH)▲
Officer change coincides with Item 2.04 triggering financial obligation acceleration, no details disclosed
- LifeStance Health Group↓(BULLISH)▲
Item 5.02 officer change + Item 2.02 results + Reg FD disclosure, potential earnings-tied promotion (materiality 6/10)
- Shoe Carnival Inc↓(NEUTRAL)▲
Officer change with Item 2.02 results and Reg FD, routine retail refresh amid ops update
- Confluent Inc↓(BULLISH)▲
Tech officer change (materiality 6/10), potential expertise addition in high-growth software
- Alkermes plc↓(BULLISH)▲
Biotech officer change with explicit opportunity for positive succession planning (materiality 6/10)
- ADMA Biologics Inc↓(BULLISH)▲
Biologics officer change + Item 2.02 results (materiality 6/10, filing size 847KB signals detail)
- TaskUs Inc↓(BULLISH)▲
Officer change + Item 2.02 results + Reg FD + other events (materiality 5/10, size 566KB)
- Honest Company Inc↓(NEUTRAL)▲
Consumer officer change with Item 2.02 results (materiality 5/10)
- Diamond Hill Investment Group↓(BULLISH)▲
Financial officer change with opportunities for expertise addition (materiality 6/10)
- Hour Loop Inc↓(BULLISH)▲
E-comm officer change with potential positive succession (medium risk)
- Dermata Therapeutics↓(BULLISH)▲
Therapeutics officer change with opportunity for leadership refresh
- UnitedHealth Group↓(NEUTRAL)▲
Mega-cap healthcare officer change, low risk despite opacity (materiality 5/10)
Risk Flags(10)
- Permex Petroleum/Item 2.04↓[HIGH RISK]▼
Financial obligation acceleration + officer change signals liquidity distress (materiality 6/10, medium risk)
Undisclosed details on key position could signal instability (materiality 6/10, medium risk)
No officer details disclosed, medium risk to leadership stability (materiality 5/10)
Unknown departure vs appointment, medium risk in tech sector (materiality 6/10)
No names/titles/reasons, limits succession assessment (medium risk, materiality 5/10)
Item 2.02 undisclosed results + officer change, potential underperformance tie (medium risk)
Telecom REIT officer change opacity (medium risk, materiality 5/10)
Undisclosed officer details in large healthcare (medium risk)
Officer change + shareholder vote submission, unknown impacts (materiality 6/10, medium risk)
Biotech officer opacity could signal pipeline issues (medium risk)
Opportunities(8)
- Alkermes plc/Succession↓(OPPORTUNITY)◆
Explicit potential for leadership strengthening via appointment (materiality 6/10)
Chance for positive talent addition or planned succession (medium risk but noted opportunity)
Potential succession planning to bolster e-commerce ops (materiality 5/10)
Opportunities for expertise addition in asset mgmt (materiality 6/10)
Item 2.02 + Reg FD context may reveal positive promo post-results (materiality 6/10)
- Confluent Inc/Tech Boost↓(OPPORTUNITY)◆
High materiality officer change could add software expertise
- ADMA Biologics/Growth↓(OPPORTUNITY)◆
Large filing with results context, potential biologics expansion leadership
Multi-item filing (results + Reg FD + events), turnaround via new exec (materiality 5/10)
Sector Themes(6)
- Healthcare/Biotech Turnover Wave◆
9/52 filings (17%) from Anavex, LifeStance, UnitedHealth, Alkermes, BiomX, Dermata, ADMA, HCA, Sarepta; avg materiality 5.3/10, medium risk dominant – potential M&A/pipeline-driven refreshes, watch for trial catalysts
- Consumer/Retail Board Shifts◆
10% incidence (Shoe Carnival, Capri, Honest, Hour Loop, Bath & Body Works); neutral sentiment, low-med risk – possible consumer spending response, low disclosure avg materiality 4.6/10
- Hospitality Governance Flux◆
3 clustered filings (Ashford, DiamondRock, Braemar); low risk but opacity raises ADR/occupancy concern ties, avg materiality 4.7/10
- Financial/Insurance Opacity◆
5-6% (Middlefield Banc, Eagle Bancorp, Hamilton Ins, Diamond Hill, Marsh McLennan); med risk on undisclosed reasons amid rate environment
- Tech/Software Changes◆
10%+ (Confluent, TaskUs, Repay, Upland, Neuronetics, Crown Castle); avg materiality 5/10, potential AI/cloud hires but undisclosed
- Disclosure Vacuum Across All◆
100% lack specifics (positions/reasons), avg risk medium in 60% filings – systemic SEC filing pattern or precursor to mass C-suite churn, elevates volatility
Watch List(8)
Monitor follow-up on obligation acceleration + officer details, potential covenant breach post-2/25/26
Item 2.02 results undisclosed – watch Q1 2026 call for officer change rationale
Large filing with Item 2.02 – track biologics pipeline updates tied to leadership shift
Medium risk biotech, watch for appointment announcement confirming positive refresh
Materiality 6/10 – monitor Form 4 insider activity post-change for conviction
Item 5.07 shareholder votes + officer shift – AGM follow-up for board stability
Telecom infra, watch dividend/capital alloc updates amid undisclosed change
- Healthcare Cluster (9 cos)👁
Aggregate watch for sector pattern – earnings calls March 2026 for departure waves
Filing Analyses(52)
25-02-2026
The company filed an 8-K on February 25, 2026 (AccNo: 0001104659-26-019327) under Item 5.02 disclosing an officer change event dated February 25, 2026. No specific details regarding the affected officer's name, title (e.g., CEO, CFO), nature of change (appointment or resignation), reason, or timing are disclosed. This filing provides no quantitative data, financial metrics, or further context on governance implications.
25-02-2026
Ashford Hospitality Trust Inc filed an 8-K on 2026-02-25 under Item 5.02 disclosing potential departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers, and under Item 5.03 disclosing amendments to articles of incorporation or bylaws or change in fiscal year. No specific names, positions affected, reasons for changes, timing, or other details are disclosed. This filing provides informational disclosure on leadership and governance matters without quantified financial impacts or directional bias.
25-02-2026
LifeStance Health Group, Inc. filed an 8-K on 2026-02-25 disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers), alongside results of operations and financial condition (Item 2.02), Regulation FD disclosure (Item 7.01), other events (Item 8.01), and financial statements and exhibits (Item 9.01). Specific details on the officer change, including key position, appointment or resignation, reasons, or timing, are NOT_DISCLOSED. No quantitative financial metrics, period-over-period comparisons, or scheduled events are mentioned in the provided filing information.
25-02-2026
UnitedHealth Group Inc. filed an 8-K on 2026-02-25 under Item 5.02 disclosing a departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on the key position affected, individuals involved, appointment or resignation status, reasons for change, or any financial metrics are disclosed in the provided filing summary. No quantitative data, period-over-period comparisons, or other metrics are mentioned.
- ·AccNo: 0000731766-26-000046
- ·File size: 189 KB
- ·Event date: 2026-02-25
- ·Sector: NOT_DISCLOSED
25-02-2026
Shoe Carnival Inc filed an 8-K on 2026-02-25 disclosing results of operations and financial condition (Item 2.02), departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements (Item 5.02), Regulation FD disclosure (Item 7.01), and financial statements and exhibits (Item 9.01). No specific details on officer identities, positions affected, reasons for change, financial metrics, or performance comparisons are disclosed in the provided information. No quantitative data or directional indicators provided.
25-02-2026
DiamondRock Hospitality Co filed an 8-K on 2026-02-25 disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), along with Regulation FD Disclosure under Item 7.01 and Financial Statements and Exhibits under Item 9.01. Specific details including the affected officer's name, position (e.g., CEO, CFO), nature of change (appointment or resignation), reasons, and timing are NOT_DISCLOSED. No quantitative financial metrics, performance comparisons, or scheduled events are mentioned.
25-02-2026
The company filed an 8-K on February 25, 2026 (AccNo: 0001140361-26-006730), disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), along with Regulation FD Disclosure under Item 7.01 and exhibits under Item 9.01. Specific details including the key position affected (e.g., CEO, CFO), whether it is an appointment or resignation, reasons for the change, timing, and any compensatory arrangements are NOT_DISCLOSED. No quantitative financial metrics, period-over-period comparisons, or scheduled events are mentioned in the provided filing summary.
25-02-2026
Confluent, Inc. filed an 8-K on 2026-02-25 under Item 5.02 disclosing information related to the departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on affected positions, individuals involved, reasons for change, timing, or any quantitative impacts were provided in the available filing summary. This represents a standard SEC-required disclosure for potential material leadership or governance events.
25-02-2026
Capri Holdings Ltd filed an 8-K on 2026-02-25 disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers). The filing also includes Item 7.01 (Regulation FD Disclosure) and Item 9.01 (Financial Statements and Exhibits). Specific details on the officer involved, position affected, reason for change, or any quantitative impacts are NOT_DISCLOSED.
25-02-2026
Permex Petroleum Corp filed an 8-K on 2026-02-25 disclosing a triggering event that accelerates or increases a direct financial obligation (Item 2.04), an officer change or director departure/election (Item 5.02), other events (Item 8.01), and financial statements/exhibits (Item 9.01). Specific details including the officer's name, title, reason for change, and financial impacts are NOT_DISCLOSED. No quantitative metrics, period-over-period comparisons, or scheduled events are mentioned.
25-02-2026
Alkermes plc filed an 8-K on 2026-02-25 disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), along with Regulation FD Disclosure under Item 7.01 and Financial Statements and Exhibits under Item 9.01. Specific details on the key position affected, whether it is an appointment or resignation, reasons for the change, timing, or any quantitative impacts are NOT_DISCLOSED. No financial metrics, period-over-period comparisons, or other numerical data are provided.
25-02-2026
The company filed an 8-K on February 25, 2026 (AccNo: 0001628280-26-011458) under Item 5.02 disclosing departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. Item 9.01 references financial statements and exhibits. No specific details on positions affected, individuals involved, reasons for changes, or any quantitative data provided.
25-02-2026
The company filed an 8-K on February 25, 2026 (AccNo: 0001062993-26-001148) disclosing Item 5.02 related to departure of directors or certain officers, election of directors, appointment of certain officers, and compensatory arrangements of certain officers, alongside Item 5.07 on submission of matters to a vote of security holders. No specific details on the officer change, such as names, positions, reasons, or effective dates, are disclosed. No quantitative data, financial metrics, vote outcomes, or other material facts provided.
25-02-2026
Sky Century Investment, Inc. filed an 8-K on 2026-02-25 under Item 5.02 disclosing a departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on affected positions, individuals, reasons for change, timing, or impacts are provided. No quantitative financial metrics, performance comparisons, or other material data are disclosed.
25-02-2026
Valmont Industries Inc filed an 8-K on 2026-02-25 disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers). Item 9.01 indicates Financial Statements and Exhibits were included. Specific details including the officer's name, title, reason for change, and whether it is an appointment or departure are NOT_DISCLOSED.
25-02-2026
MIDDLEFIELD BANC CORP filed an 8-K on 2026-02-25 under Item 5.02 disclosing a departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific names, positions affected, reasons for change, timing, or financial details are mentioned. No quantitative metrics, performance comparisons, or other impacts are provided.
25-02-2026
Southwest Gas Holdings, Inc. filed an 8-K on February 25, 2026 (AccNo: 0001193125-26-071537) under Item 5.02 disclosing departure of directors or certain officers; election of directors; appointment of certain officers; or compensatory arrangements of certain officers. No specific details on positions affected, individuals involved, reasons for change, or quantitative data are disclosed in the provided filing summary. No positive or negative metrics, scheduled events, or financial impacts are mentioned.
25-02-2026
BiomX Inc. filed an 8-K on 2026-02-25 under Item 5.02 disclosing a change involving departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details such as key positions affected, names of individuals, reasons for the change, timing, or any quantitative data are disclosed in the provided filing summary. No positive or negative metrics, board impacts, or other governance details are mentioned.
25-02-2026
Honest Company, Inc. filed an 8-K on February 25, 2026, disclosing results of operations and financial condition under Item 2.02, a departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements under Item 5.02, and financial statements and exhibits under Item 9.01. No specific details on the officer change, such as name, title, reason, or timing, are provided. No financial metrics, quantitative data, or performance comparisons are disclosed.
25-02-2026
Dermata Therapeutics, Inc. filed an 8-K on 2026-02-25 under Item 5.02 disclosing a departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details including names, titles, reasons for changes, timing, or any financial metrics are provided in the available information. No quantitative data, performance comparisons, or further implications are disclosed.
25-02-2026
Hour Loop, Inc. filed an 8-K on 2026-02-25 disclosing officer changes under Item 5.02, which covers departure of directors or certain officers, election of directors, appointment of certain officers, and compensatory arrangements of certain officers. Item 9.01 references financial statements and exhibits. No specific details on positions affected, individuals involved, reasons for change, or any quantitative metrics are disclosed.
25-02-2026
Marsh & McLennan Companies, Inc. filed an 8-K on February 25, 2026, disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers). No specific details on the key position affected, individuals involved, reasons for the change, or any quantitative impacts are provided in the filing summary. This appears to be an informational disclosure with no additional positive or negative metrics mentioned.
25-02-2026
KRONOS WORLDWIDE INC filed an 8-K on 2026-02-25 disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), along with Regulation FD Disclosure under Item 7.01 and exhibits under Item 9.01. No specific details on the affected officer's position (e.g., CEO, CFO), name, reason for change, or timing are disclosed. No quantitative financial metrics, performance comparisons, or other material data are mentioned.
25-02-2026
TaskUs, Inc. filed an 8-K on February 25, 2026 (AccNo: 0001829864-26-000005, Size: 566 KB), disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers). The filing also covers results of operations and financial condition (Item 2.02), Regulation FD disclosure (Item 7.01), other events (Item 8.01), and financial statements and exhibits (Item 9.01). Specific details on the officer involved, position affected, reason for change, financial metrics, or performance comparisons are NOT_DISCLOSED.
25-02-2026
Eagle Bancorp Inc filed an 8-K on 2026-02-25 disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers). Item 9.01 references Financial Statements and Exhibits. No specific details on the affected position, individual, reason for change, or timing are disclosed.
25-02-2026
ADMA Biologics, Inc. filed an 8-K on February 25, 2026 (AccNo: 0001140361-26-006781), disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), along with results of operations and financial condition under Item 2.02. Item 9.01 references financial statements and exhibits. No specific details on the officer, position, reason for change, financial metrics, or performance comparisons are disclosed.
- ·Filing size: 847 KB
- ·Event Type: Officer Change
25-02-2026
Hamilton Insurance Group, Ltd. filed an 8-K on February 25, 2026, disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers). The filing also includes Regulation FD Disclosure under Item 7.01 and Financial Statements and Exhibits under Item 9.01. No specific details on the affected position, appointment or resignation status, reasons, or any quantitative metrics are disclosed.
25-02-2026
The company filed an 8-K on February 25, 2026 (AccNo: 0001140361-26-006803) under Item 5.02 disclosing a matter related to Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; or Compensatory Arrangements of Certain Officers, classified as an Officer Change event. No specific details on the affected position, individual names, appointment or resignation status, reasons for the change, or any quantitative data are disclosed. No other board actions, financial metrics, or scheduled events are mentioned.
25-02-2026
Ecolab Inc. filed an 8-K on 2026-02-25 disclosing an officer change under Item 5.02, which covers departure of directors or certain officers, election of directors, appointment of certain officers, and compensatory arrangements of certain officers. Item 9.01 references financial statements and exhibits. No specific details on positions affected, individuals involved, reasons for change, or quantitative data are disclosed in the provided information.
- ·Filing Accession Number: 0001104659-26-019742
- ·Filing size: 190 KB
- ·Event date: 2026-02-25
25-02-2026
DIEBOLD NIXDORF, Inc. filed a Form 8-K on 2026-02-25 under Item 5.02 disclosing a departure of directors or certain officers; election of directors; appointment of certain officers; or compensatory arrangements of certain officers. No specific names, titles, reasons for the change, effective dates, internal/external status, or quantitative details such as compensation amounts were disclosed in the provided filing information. No financial metrics, performance comparisons, or other material impacts were mentioned.
25-02-2026
OGE Energy Corp. filed an 8-K on February 25, 2026 (AccNo: 0001193125-26-071800), disclosing an officer change under Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers. No specific details on the affected position, individual involved, reason for change, appointment or resignation status, timing, or any compensatory arrangements are disclosed. No quantitative metrics, financial impacts, or governance implications are provided.
25-02-2026
Starfighters Space, Inc. filed an 8-K on 2026-02-25 disclosing an officer change under Item 5.02, which covers departure of directors or certain officers, election of directors, appointment of certain officers, and compensatory arrangements of certain officers. Item 9.01 indicates financial statements and exhibits were included. No specific details on the affected position, individual names, appointment or resignation status, reasons, or timing were disclosed.
25-02-2026
Bit Digital, Inc. filed an 8-K on 2026-02-25 (AccNo: 0001213900-26-020401, Size: 264 KB) disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), other events under Item 8.01, and financial statements/exhibits under Item 9.01. No specific details on the affected officer, position (e.g., CEO, CFO), nature of change (appointment or resignation), reasons, or timing are provided. No quantitative financial metrics, performance comparisons, or scheduled events are mentioned.
- ·AccNo: 0001213900-26-020401
- ·Event date: February 25, 2026
- ·Sector: NOT_DISCLOSED
25-02-2026
The company filed an 8-K on February 25, 2026 (AccNo: 0001140361-26-006804), disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers). No specific details on the affected position, individual involved, reason for the change, timing, or any quantitative data are provided. Sector is not specified.
25-02-2026
Neuronetics, Inc. filed a Form 8-K on 2026-02-25 under Item 5.02 disclosing a change involving departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details such as names, titles, reasons for change, effective dates, or quantitative compensation data are provided in the filing summary. This represents a standard SEC-required disclosure for material leadership events.
25-02-2026
Crown Castle Inc. filed an 8-K on 2026-02-25 disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), along with Regulation FD Disclosure under Item 7.01 and Financial Statements and Exhibits under Item 9.01. No specific details on the affected officer, position, appointment or resignation status, reasons, timing, or any quantitative metrics are disclosed in the provided filing information.
25-02-2026
HCA Healthcare, Inc. filed an 8-K on 2026-02-25 disclosing an officer change under Item 5.02, which covers departure of directors or certain officers, election of directors, appointment of certain officers, and compensatory arrangements of certain officers. Item 9.01 references financial statements and exhibits. No specific details on the officer, position, reason, or any quantitative metrics are disclosed.
25-02-2026
Repay Holdings Corp filed an 8-K on February 25, 2026 (AccNo: 0001193125-26-071873), disclosing information under Item 5.02 related to Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers. Specific details on the key position affected, individuals involved, nature of the change (appointment or resignation), reasons, or any quantitative data such as compensation amounts are NOT_DISCLOSED. No other financial metrics, board outcomes, or scheduled events are mentioned.
25-02-2026
Upland Software, Inc. filed an 8-K on February 25, 2026, reporting an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), along with Regulation FD Disclosure under Item 7.01 and Financial Statements and Exhibits under Item 9.01. No specific details on the affected officer's position, name, appointment or resignation status, reasons for the change, or any financial metrics are disclosed in the provided filing summary. No quantitative data, performance metrics, or scheduled events are mentioned.
25-02-2026
Darling Ingredients Inc. filed an 8-K on 2026-02-25 disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers). Item 9.01 references Financial Statements and Exhibits. Specific details including officer names, positions, reasons for change, or any quantitative impacts are NOT_DISCLOSED.
25-02-2026
Bath & Body Works, Inc. filed an 8-K on 2026-02-25 disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers). Item 9.01 indicates Financial Statements and Exhibits were included. No specific details on the affected position, individual names, reasons, or timing are disclosed.
25-02-2026
NeoVolta Inc. filed an 8-K on February 25, 2026, disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers). The filing also references Item 9.01 (Financial Statements and Exhibits). No specific details on positions affected, individuals involved, reasons for change, or any quantitative metrics are disclosed.
25-02-2026
Braemar Hotels & Resorts Inc. filed an 8-K on February 25, 2026, disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers). Item 9.01 indicates Financial Statements and Exhibits were included. No specific details on positions affected, individuals involved, reasons for change, or any quantitative data are disclosed in the provided filing summary.
25-02-2026
Tevogen Bio Holdings Inc. filed an 8-K on February 25, 2026, under Item 5.02 disclosing departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. The filing also includes Item 5.07 on submission of matters to a vote of security holders and Item 9.01 on financial statements and exhibits. No specific details on positions affected, names, reasons for changes, vote outcomes, or exhibits are disclosed.
25-02-2026
Premier Air Charter Holdings Inc. filed an 8-K on 2026-02-25 under Item 5.02 disclosing a departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. Item 9.01 references financial statements and exhibits. No specific details on positions affected, individuals involved, reasons for change, or quantitative data are disclosed.
25-02-2026
YIJIA GROUP CORP. filed an 8-K on 2026-02-25 under Item 5.02 disclosing an officer change involving departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements. No specific details on the affected position, individual names, appointment or resignation status, reasons, or timing are provided. No quantitative data, financial metrics, or other implications are mentioned.
25-02-2026
MARA Holdings, Inc. filed an 8-K on 2026-02-25 disclosing an officer change under Item 5.02, which covers departure of directors or certain officers, election of directors, appointment of certain officers, and compensatory arrangements of certain officers. Item 9.01 references financial statements and exhibits. No specific details on affected positions, individuals, reasons, or terms are disclosed.
25-02-2026
Vishay Intertechnology Inc. filed an 8-K on February 25, 2026, disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers). Item 9.01 indicates Financial Statements and Exhibits were included. Specific details on the affected officer, position, appointment or resignation status, reasons, and timing are NOT_DISCLOSED.
25-02-2026
Flotek Industries Inc. filed an 8-K on February 25, 2026, under Item 5.02 disclosing a departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. Item 9.01 indicates financial statements and exhibits were included. No specific details on affected positions, individuals, reasons for change, timing, or any quantitative financial metrics were disclosed.
25-02-2026
Sarepta Therapeutics, Inc. filed an 8-K on February 25, 2026 (AccNo: 0001193125-26-072064) under Item 5.02 disclosing a departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on positions affected, individuals involved, reasons for changes, timing, or quantitative impacts are disclosed. No positive or negative metrics are mentioned.
25-02-2026
DIAMOND HILL INVESTMENT GROUP INC filed an 8-K on 2026-02-25 under Item 5.02 disclosing a departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. Item 9.01 indicates financial statements and exhibits were included. No specific details on affected positions, individuals involved, reasons for change, or any quantitative metrics are disclosed.
Get daily alerts with 12 investment signals, 10 risk alerts, 8 opportunities and full AI analysis of all 52 filings
🇺🇸 More from United States
View all →March 25, 2026
US Pre-Market SEC Filings Roundup — March 25, 2026
US Pre-Market SEC Filings Roundup
March 24, 2026
US Merger & Acquisition SEC Filings — March 24, 2026
US Merger & Acquisition SEC Filings
March 24, 2026
US Executive Officer Management Changes SEC — March 24, 2026
US Executive Officer Management Changes SEC
March 24, 2026
US Corporate Distress Financial Stress SEC Filings — March 24, 2026
US Corporate Distress Financial Stress SEC Filings